Overall, these results suggest that uPAR+ cells play a key role in chronic age-related intestinal inflammation and that their elimination, either therapeutically or prophylactically, with uPAR CAR T cells can significantly ameliorate intestinal inflammaging and modify the microbiome composition. Here, PLAUR is linked to inflammatory response.